The past decade has seen an increased global focus on transparency of the relationship between the medical devices industries and healthcare delivery systems. This started in 2010 when the USA passed the Sunshine Act to require companies to report payments made to US-based healthcare institutions into a government-run registry. Since then, similar systems have been established in the Netherlands and France.
The Independent Medicines and Medical Devices Safety (IMMDS) Review recommended that there should be mandatory reporting for industry payments, which the Government has accepted. Legislation will be progressed through parliament to put a legal duty on companies to collect and publish information on their payments to healthcare professionals and organisations.
A public consultation will be held later in 2022 to define the exact scope of the reporting process. Medilink is already in discussion with government agencies on this topic and would like to hear from you if you have any thoughts on what you believe should be considered when developing the scope and operational guidelines for this new legislation. Contact firstname.lastname@example.org.